Search results
Chardan Capital Cuts Seres Therapeutics (NASDAQ:MCRB) Price Target to $6.00
ETF DAILY NEWS· 6 days agoSeres Therapeutics (NASDAQ:MCRB – Free Report) had its price objective decreased by Chardan Capital from $8.00 to $6.00 in a report published on Wednesday morning, Benzinga reports. Chardan ...
ADMA Biologics (NASDAQ:ADMA) Price Target Raised to $10.00 at Raymond James
ETF DAILY NEWS· 4 days agoADMA Biologics (NASDAQ:ADMA – Free Report) had its price objective upped by Raymond James from $8.00 to $10.00 in a report issued on Friday morning, Benzinga reports. Mizuho lifted their price ...
Jasper Therapeutics, Inc. Expected to Post Q2 2024 Earnings of ($0.96) Per Share (NASDAQ:JSPR)
ETF DAILY NEWS· 13 hours agoJasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Research analysts at William Blair raised their Q2 2024 earnings estimates for Jasper Therapeutics in a research note ...
Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences
Digital Journal· 3 hours agoCompany anticipates that its future plan will restore and enhance shareholder value. About NeuraSeed BCI NeuraSeed BCI is...NeuraSeedBCI.com . About Psycheceutical Bioscience ...
Anixa Biosciences, Inc. (NASDAQ:ANIX) Sees Significant Increase in Short Interest
ETF DAILY NEWS· 13 hours agoAnixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest ...
Mizuho Trims uniQure (NASDAQ:QURE) Target Price to $6.00
ETF DAILY NEWS· 6 days agoSeveral other equities research analysts have also weighed in on QURE. Royal Bank of Canada reissued an outperform rating and set a $28.00 price objective on shares of uniQure in a research ...
Apollon Wealth Management LLC Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)
ETF DAILY NEWS· 2 days ago(NASDAQ:AXON – Free Report) in the fourth quarter, according to its most recent 13F...the Securities...
Brokerages Set Immunome, Inc. (NASDAQ:IMNM) PT at $30.50
ETF DAILY NEWS· 2 days agoImmunome, Inc. (NASDAQ:IMNM – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are covering the company, MarketBeat.com reports ...
AGF Management Ltd. Has $2.60 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR)
ETF DAILY NEWS· 1 day ago(NASDAQ:UTHR – Free Report) by 11.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund
NBC Securities Inc. Purchases 219 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
ETF DAILY NEWS· 2 days agoNBC Securities Inc. grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.9% during the fourth quarter, according to the company in its most ...